home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410o.zip
/
M94A2790.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
3KB
|
46 lines
Document 2790
DOCN M94A2790
TI Effect of long term therapy with glycyrrhizin for HIV infection in a
hemophilia patient.
DT 9412
AU Imaizumi M; Goto Y; Tada K; Mori K; Dept. of Pediatrics, Tohoku Univ.
School of Medicine, Sendai,; Japan.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):224 (abstract no. PB0326). Unique
Identifier : AIDSLINE ICA10/94369785
AB Glycyrrhizin (GL), an aqueous extract of licorice root in Chinese
medicine, has as an antiinflammatory as well as anti-viral effects.
Recently, based on in vitro studies proving anti-HIV effects of GL, a
clinical trial of GL for HIV infection has been under investigation. In
this report, we present a patient who has been treated only with a
long-term GL therapy. Case presentation. The patient was a 5-year-boy
when he was diagnosed as Hemophilia A. At 9 years of age, he was
presented with suppurative skin lesions and lymphadenopathy, and
diagnosed as HIV infection in asymptomatic carrier (AC) stage based on
diminished reaction in skin test, decreased response of his lymphocytes
to T-cell mitogens, low CD4+ T-cell counts in peripheral blood
(651/microliters) with a decreased ratio of CD4/CD8 (0.37), and
positivity for antibody against HIV. Initially, GL was administrated
intravenously with GL solution (2 mg/ml) dissolved in saline together
with glycine and cysteine in a dose 5 ml/kg/day for 3 weeks, and then
doses of infusion were gradually reduced over 2 years and 2 months.
Then, he has been treated with oral administration of GL up to now.
Results and Conclusion CD4+ T-cell counts increased more than
1000/microliters by several weeks and CD4/CD8 ratio improved to 1.0 by 3
months after an initiation of GL administration. Mild lymphadenopathy
disappeared by 3 years of GL administration, and he has been staying in
AC stage for 7 years and 8 months. The examinations in recent two years
revealed alterations of CD4+ T-cell counts and CD4/CD8 ratios within 400
to 1000/microliters and 0.55 to 0.71, respectively, in a slowly
declining course. The clinical course of this patient suggests that GL
therapy for a long term may be useful for decelerating disease
progression if started with high doses in an early stage of HIV
infection.
DE Adjuvants, Immunologic/*THERAPEUTIC USE Case Report Child, Preschool
Glycyrrhetinic Acid/*ANALOGS & DERIVATIVES/THERAPEUTIC USE
Hemophilia/COMPLICATIONS Human HIV Infections/COMPLICATIONS/*THERAPY
Leukocyte Count Male T4 Lymphocytes MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).